Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Share this content:

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Sponsor and Collaborators     

Michelle Stevens-Brogan, BS,MS     
TGen Clinical Reserch Services at Scottsdale Healthcare
Scottsdale, Arizona, United States, 85258
Contact: Lisa Blaydorn, RN     480-323-1562    
Principal Investigator: Ramesh K. Ramanathan, MD            

Pacific Cancer Medical Center     
Anaheim, California, United States, 92081
Contact: Elizabeth Garcia     714-999-1465 ext 240    
Principal Investigator: Venna Charu, MD            

Space Coast Medical Associates     
Titusville, Florida, United States, 32796
Contact: Terry McFarland, BSN     321-268-4200 ext 3168    
Principal Investigator: Firas Muwalla, MD            

Investigative Clinical Research of Indiana     
Indianapolis, Indiana, United States, 46260
Contact: Heather Rather, BS, CCRP     317-297-1136    
Contact: Kimberly Van Norn, CCRP     317-297-1136    
Principal Investigator: Robert Manges, MD            

Kenthucky Cancer Clinic     
Hazard, Kentucky, United States, 41701
Contact: Tracie McDaniel     606-439-2239    
Principal Investigator: Hassan Ghazal, MD            

Park Nicollet Institute     
St. Louis Park, Minnesota, United States, 55426
Contact: Laura Maybon     952-993-5710    
Contact: Karen Swenson     952-993-6071    
Principal Investigator: Michaela Tsai, MD            

Beth Israel Cancer Center     
New York, New York, United States, 10003
Contact: Damien Francois     212-844-8070    
Principal Investigator: Peter Kozuch, MD
Columbia University     (Active, not recruiting)
New York, New York, United States, 10032
University of Rochester     Recruiting
Rochester, New York, United States, 14642
Contact: Charcy Salamone     585-273-5474    
Principal Investigator: Alok Khorana, MD            

Summa Health System     
Akron, Ohio, United States, 44304
Contact: Joyce Neading     330-375-4221    
Contact: Ann Stone     330-375-6578    
Principal Investigator: Sameer Mahesh, MD
Gabrail Cancer Center Research     
Canton, Ohio, United States, 44718
Contact: Carrie Smith, R.N.     330-492-3345    
Contact: Amber Miller     330-492-3345 ext 213    
Principal Investigator: Nashat Gabrail, MD            

Gettysburg Cancer Center     
Gettysburg, Pennsylvania, United States, 17325
Contact: Vanessa Hardman     717-334-4033    
Principal Investigator: Satish Shah, MD            

Charleston Hematology Oncology Associates     
Charleston, South Carolina, United States, 29414
Contact: Deborah McNeal, RN, OCN     843-266-2540    
Contact: Susan Gibson, RN, OCN     843-266-0694    
Principal Investigator: George F Geils Jr, MD            

South Carolina Cancer Specialists, PA     
Hilton Head, South Carolina, United States, 29926
Contact: Becky McCunn     843-689-2895 ext 30    
Contact: Teressa Williams     843-689-9267    
Principal Investigator: Gary Thomas, MD            

Associates in Oncology and Hematology     
Chattanooga, Tennessee, United States, 37404
Contact: Jill Metcalf, CCRP     423-622-2337    
Contact: Jillian Mitchell     423-622-2337    
Principal Investigator: Jitendra G Ghandi, MD            

Sammons Cancer Center     
Dallas, Texas, United States, 75246
Contact: Claire Peterson     214-370-1949    
Contact: Jonathan Huntzinger     214-370-1900        
Principal Investigator: Carlos Becerra, MD            

University of Vermont/Vermont Cancer Center     
Burlington, Vermont, United States, 05401
Contact: Karen Lepuschenko     802-656-9925    
Principal Investigator: Steven Ades, MD Identifier

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs